SURGICAL-MANAGEMENT OF PROSTATE-CANCER - CONTEMPORARY RESULTS WITH ANATOMIC RADICAL PROSTATECTOMY

被引:0
|
作者
CATALONA, WJ [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,DIV UROL SURG,ST LOUIS,MO
关键词
NERVE-SPARING RADICAL PROSTATECTOMY; ANATOMIC RADICAL PROSTATECTOMY; RADICAL PROSTATECTOMY; SURGICAL MANAGEMENT OF PROSTATE CANCER;
D O I
10.1002/1097-0142(19950401)75:7+<1903::AID-CNCR2820751624>3.0.CO;2-#
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In men with clinically localized prostate cancer whose life expectancy exceeds 10 years, radical prostatectomy has been considered the preferred treatment. When the cancer is confined to the prostate, radical prostatectomy has yielded excellent long term, cancer-free survival results; however, when the cancer escapes from the prostate, recurrence rates increase progressively with the degree of cancer spread. The morbidity and mortality rates for prostate cancer are high because, in the past, the cancer usually was detected late. Recent advances in early detection and surgical technique have increased the opportunities to improve treatment outcomes. However, some authors have questioned the preference of radical prostatectomy over expectant management. This article presents the author's experience with anatomic radical prostatectomy, in which an undetectable postoperative serum prostate specific antigen (PSA) level was used to measure the success of therapy in approximately 1000 patients treated during the past decade. The results are compared with those reported from other centers that also have ample experience with this operation. Together, these results suggest that contemporary anatomic radical prostatectomy provides unexcelled cancer control with low mortality and morbidity rates. With PSA screening, it is now possible to detect prostate cancers sooner, when patients are younger and more of the tumors are organ confined. Therefore, the treatment outcomes should be correspondingly more favorable in the future. Prospective, randomized studies are underway to compare the results of radical prostatectomy with those of expectant management in patients with clinically localized disease. However, until other treatments are proved to be as effective as radical prostatectomy in a representative patient population, radical prostatectomy should be considered the preferred treatment for men with localized prostate cancer whose life expectancy exceeds 10 years.
引用
收藏
页码:1903 / 1908
页数:6
相关论文
共 50 条
  • [1] SURGICAL-MANAGEMENT OF PROSTATE-CANCER
    AREF, I
    CANCER, 1995, 76 (09) : 1682 - 1683
  • [2] SURGICAL-MANAGEMENT OF PROSTATE-CANCER - REPLY
    CATALONA, WJ
    CANCER, 1995, 76 (09) : 1683 - 1684
  • [3] Contemporary results of anatomic radical prostatectomy
    Catalona, WJ
    Ramos, CG
    Carvalhal, GF
    CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (05) : 282 - 296
  • [4] RADICAL PROSTATECTOMY FOR PROSTATE-CANCER IN ISRAEL
    GOLDWASSER, B
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1988, 24 (08): : 451 - 452
  • [5] RADICAL PROSTATECTOMY OR RADIOTHERAPY IN LOCALIZED PROSTATE-CANCER
    GERARD, JP
    ROMESTAING, P
    PRESSE MEDICALE, 1990, 19 (44): : 2037 - 2038
  • [6] THE ROLE OF RADICAL PROSTATECTOMY IN THE TREATMENT OF PROSTATE-CANCER
    BRENDLER, CB
    WALSH, PC
    CA-A CANCER JOURNAL FOR CLINICIANS, 1992, 42 (04) : 212 - 222
  • [7] HETEROGENEITY OF PROSTATE-CANCER IN RADICAL PROSTATECTOMY SPECIMENS
    AIHARA, M
    WHEELER, TM
    OHORI, M
    SCARDINO, PT
    UROLOGY, 1994, 43 (01) : 60 - 66
  • [8] RESULTS OF RADICAL PROSTATECTOMY AND ADJUVANT THERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED, CLINICAL STAGE TC, PROSTATE-CANCER
    YAMADA, AH
    LIESKOVSKY, G
    PETROVICH, Z
    CHEN, SC
    GROSHEN, S
    SKINNER, DG
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (04): : 277 - 285
  • [9] TRANSCOCCYGEAL RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE-CANCER - EARLY CLINICAL-RESULTS
    RIGATTI, P
    DAPOZZO, L
    FRANCESCA, F
    BROGLIA, L
    MONTORSI, F
    GUAZZONI, G
    SCATTONI, V
    EUROPEAN UROLOGY, 1993, 24 : 29 - 33
  • [10] TREATMENT WITH FINASTERIDE FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE-CANCER
    ANDRIOLE, G
    LIEBER, M
    SMITH, J
    SOLOWAY, M
    SCHROEDER, F
    KADMON, D
    DEKERNION, J
    RAJFER, J
    BOAKE, R
    CRAWFORD, D
    RAMSEY, E
    PERREAULT, J
    TRACHTENBERG, J
    FRADET, T
    BLOCK, N
    MIDDLETON, R
    NG, J
    FERGUSON, D
    GORMLEY, G
    UROLOGY, 1995, 45 (03) : 491 - 497